Susanna Hallberg

机构：Danderyds sjukhus, Karolinska Institutet · ORCID：0000-0002-7912-3462

发表论文 4 篇 · 总被引 157 次 · h-index 2

代表论文

• Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial (2022 · The Lancet Neurology · 被引 140)
• Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study (2024 · European Journal of Neurology · 被引 15)
• [Rapid improvement of tick-borne encephalitis after treatment with corticosteroids]. (2017 · PubMed · 被引 2)
• Late-Onset Neutropenia After Rituximab in Multiple Sclerosis (2026 · Neurology Neuroimmunology & Neuroinflammation)